Raymond James Financial Services Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$21.3M Sell
215,084
-70,955
-25% -$7.01M 0.03% 524
2024
Q2
$26.5M Sell
286,039
-52,017
-15% -$4.82M 0.04% 417
2024
Q1
$32.1M Buy
338,056
+83,473
+33% +$7.92M 0.05% 359
2023
Q4
$22.7M Sell
254,583
-14,376
-5% -$1.28M 0.04% 438
2023
Q3
$19.6M Sell
268,959
-69,657
-21% -$5.09M 0.04% 459
2023
Q2
$28.2M Buy
338,616
+81,777
+32% +$6.8M 0.05% 354
2023
Q1
$19.6M Sell
256,839
-36,695
-13% -$2.8M 0.04% 455
2022
Q4
$24.4M Buy
293,534
+148,901
+103% +$12.4M 0.05% 369
2022
Q3
$11.5M Sell
144,633
-118,149
-45% -$9.37M 0.03% 565
2022
Q2
$19.5M Buy
262,782
+38,635
+17% +$2.87M 0.04% 407
2022
Q1
$20.1M Sell
224,147
-11,059
-5% -$994K 0.04% 446
2021
Q4
$26.3M Buy
235,206
+120,663
+105% +$13.5M 0.05% 372
2021
Q3
$14.4M Sell
114,543
-158,231
-58% -$19.9M 0.03% 538
2021
Q2
$36.9M Buy
272,774
+118,429
+77% +$16M 0.08% 266
2021
Q1
$20.9M Buy
154,345
+14,667
+11% +$1.99M 0.05% 387
2020
Q4
$19.7M Sell
139,678
-2,849
-2% -$401K 0.05% 356
2020
Q3
$15.9M Sell
142,527
-139,773
-50% -$15.6M 0.05% 367
2020
Q2
$31.6M Buy
282,300
+162,329
+135% +$18.2M 0.1% 211
2020
Q1
$9.29M Sell
119,971
-3,427
-3% -$265K 0.04% 391
2019
Q4
$11.7M Buy
123,398
+10,232
+9% +$973K 0.04% 459
2019
Q3
$8.63M Sell
113,166
-30,465
-21% -$2.32M 0.03% 506
2019
Q2
$12.6M Sell
143,631
-31,471
-18% -$2.76M 0.05% 394
2019
Q1
$15.9M Sell
175,102
-17,190
-9% -$1.56M 0.07% 321
2018
Q4
$13.8M Buy
192,292
+11,720
+6% +$841K 0.07% 293
2018
Q3
$17.3M Buy
180,572
+10,342
+6% +$992K 0.08% 281
2018
Q2
$16.2M Buy
170,230
+21,924
+15% +$2.09M 0.08% 273
2018
Q1
$13M Buy
148,306
+15,421
+12% +$1.35M 0.07% 295
2017
Q4
$11.3M Sell
132,885
-169,924
-56% -$14.4M 0.07% 318
2017
Q3
$26.2M Buy
302,809
+62,100
+26% +$5.38M 0.17% 132
2017
Q2
$18.6M Buy
240,709
+29,346
+14% +$2.26M 0.13% 188
2017
Q1
$14.7M Buy
211,363
+31,997
+18% +$2.22M 0.11% 218
2016
Q4
$10.6M Sell
179,366
-8,000
-4% -$474K 0.09% 265
2016
Q3
$12.4M Buy
187,366
+48,894
+35% +$3.24M 0.11% 226
2016
Q2
$7.49M Buy
138,472
+123,447
+822% +$6.68M 0.07% 300
2016
Q1
$776K Buy
15,025
+1,433
+11% +$74K 0.01% 1032
2015
Q4
$954K Sell
13,592
-1,723
-11% -$121K 0.01% 948
2015
Q3
$953K Buy
+15,315
New +$953K 0.02% 789